Article Name Interaction
“We’re Making Injections Fear-Free”: IntegriMedical’s Needle-Free Tech Gains Ground Across India
With over 50,000 successful uses and backing from the Serum Institute, IntegriMedical’s N-FIS system is redefining patient comfort and safety as it expands from paediatrics to gynaecology.
12th June, 2025
Implantica Showcases RefluxStop™ Breakthrough at Digestive Disease Week 2025
Groundbreaking non-active implant for acid reflux draws global attention and fuels U.S. clinical engagement at world’s premier GI conference.
27th May, 2025
Advancing Anaesthesia Technology for Better Patient Outcomes
In an exclusive interview with MedTech Spectrum, Shalin Patel, CEO of Dräger – Asia Pacific, shares insights on redefining anaesthesia care with advanced ventilation systems, green technologies, and data-driven solutions.
21st April, 2025
Seeing Brilliance in APAC: Alcon’s Vision Care Innovations and Eye Health Mission
Jason Hoffe, VP of APAC Vision Care at Alcon, discusses unmet needs, groundbreaking advancements, and the company’s commitment to transforming eye care across Asia-Pacific
03rd January, 2025
“Medtronic aims to foster collaboration with local ecosystem and stakeholders in Hyderabad”
In a significant move towards the growth of the healthcare technology sector in India, Ireland-headquartered Medtronic had announced an investment of approximately Rs 3000 crore, earlier this year, to expand the Medtronic Engineering & Innovation Center (MEIC) in Hyderabad. MEIC is Medtronic’s largest research and development (R&D) centre outside of the US. In addition, Medtronic is supporting the Government of Telangana’s efforts to position Hyderabad as a global hub for healthcare technology research and innovation. In conversation with MedTech Spectrum & BioSpectrum, Divya Prakash Joshi, Vice President & MEIC Site Leader, Medtronic talks about the new investment and the future plans of MEIC.
23rd October, 2023
“The interest of companies in biobanks has significantly increased but investments have not yet been realised”
BioBank Japan, a hospital-based multi-institutional biobank that has collected DNA, serum and medical record information from ~260,000 patients affected by one of 51 pre-defined diseases, is now launching a new phase to accelerate precision medicine and health in Japan. In an address on May 24 in Tokyo, Professor Yoichiro Kamatani, a member of the Steering Committee at BioBank Japan, presented the new phase and future direction of this important biobank for the future health of Japan. In an interaction with BioSpectrum Asia, Prof. Kamatani reveals more details about the work being done at BioBank Japan.
07th July, 2023
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer